Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy

References

• ChengMChenYXiaoWSunRTianZNK cell-based immunotherapy for malignant diseasesCell Mol Immunol201310323025223604045
   PubMed Web of Science ®Google Scholar
• PengXHQianXMaoHTargeted magnetic iron oxide nanoparticles for tumor imaging and therapyInt J Nanomedicine20083331132118990940
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev200456111649165915350294
   PubMed Web of Science ®Google Scholar
• OzolsRFHerbstRSColsonYLClinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening – a report from the American society of clinical oncologyJpn J Clin Oncol2006251146162
   Google Scholar
• ArrueboMFernández-PachecoRIbarraMRSantamaríaJMagnetic nanoparticles for drug deliveryNano Today2007232232
   Web of Science ®Google Scholar
• ShurinMRNaiditchHGutkinDWUmanskyVShurinGVChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agentsCurr Med Chem201219121792180322414087
   PubMed Web of Science ®Google Scholar
• SpencerCMFauldsDPaclitaxelDrugs19944857948477530632
   PubMed Web of Science ®Google Scholar
• de BreeETheodoropoulosPARosingHTreatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedsideCancer Treat Rev200632647148216942841
   PubMed Web of Science ®Google Scholar
• SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm2002235117919211879753
   PubMedGoogle Scholar
• FjällskogM-LFriiLBerghJPaclitaxel-induced cytotoxicity – the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoproteinEur J Cancer19943056876907915908
   PubMedGoogle Scholar
• Meerum TerwogtJNuijenBHuininkWWBeijnenJHAlternative formulations of paclitaxelCancer Treat Rev199723287959225960
   PubMed Web of Science ®Google Scholar
• ChunCLeeSMKimSYYangHKSongS-CThermosensitive poly (organophosphazene)–paclitaxel conjugate gels for antitumor applicationsBiomaterials200930122349236019178941
   PubMed Web of Science ®Google Scholar
• ChoYWLeeJLeeSCHuhKMParkKHydrotropic agents for study of in vitro paclitaxel release from polymeric micellesJ Control Release200497224925715196752
   PubMed Web of Science ®Google Scholar
• XiongWPengLChenHLiQSurface modification of MPEG-b-PCL-based nanoparticles via oxidative self-polymerization of dopamine for malignant melanoma therapyInt J Nanomedicine2015102985299625945046
   PubMed Web of Science ®Google Scholar
• WoodAJRowinskyEKDonehowerRCPaclitaxel (taxol)N Engl J Med199533215100410147885406
   PubMed Web of Science ®Google Scholar
• SinghSDashAKPaclitaxel in cancer treatment: perspectives and prospects of its delivery challengesCrit Rev Ther Drug Carrier Syst200926433337220001890
   PubMed Web of Science ®Google Scholar
• GelderblomHVerweijJNooterKSparreboomACremophor EL: the drawbacks and advantages of vehicle selection for drug formulationEur J Cancer200137131590159811527683
   PubMed Web of Science ®Google Scholar
• HennenfentKGovindanRNovel formulations of taxanes: a review. Old wine in a new bottle?Ann Oncol200617573574916364960
   PubMed Web of Science ®Google Scholar
• YuD-HLuQXieJFangCChenH-ZPeptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculatureBiomaterials20103182278229220053444
   PubMed Web of Science ®Google Scholar
• ZhangZTanSFengS-SVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials201233194889490622498300
   PubMed Web of Science ®Google Scholar
• VanSDasSKWangXSynthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)-paclitaxel nanoconju-gateInt J Nanomedicine2010582583721042550
   PubMed Web of Science ®Google Scholar
• DesaiNTrieuVYaoZIncreased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxelClin Cancer Res20061241317132416489089
   PubMed Web of Science ®Google Scholar
• RosenbergSAYangJCRestifoNPCancer immunotherapy: moving beyond current vaccinesNat Med200410990991515340416
   PubMed Web of Science ®Google Scholar
• RosenbergSAProgress in human tumour immunology and immuno-therapyNature2001411683538038411357146
   PubMed Web of Science ®Google Scholar
• SchusterMNechanskyAKircheisRCancer immunotherapyBiotechnol J20061213814716892244
   PubMedGoogle Scholar
• SerdaREParticle platforms for cancer immunotherapyInt J Nanomedicine201381683169623761969
   PubMed Web of Science ®Google Scholar
• BodeCZhaoGSteinhagenFKinjoTKlinmanDMCpG DNA as a vaccine adjuvantExpert Rev Vaccines201110449951121506647
   PubMed Web of Science ®Google Scholar
• AlvingCRPeachmanKKRaoMReedSGAdjuvants for human vaccinesCurr Opin Immunol201224331031522521140
   PubMed Web of Science ®Google Scholar
• CouperKNBlountDGRileyEMIL-10: the master regulator of immunity to infectionJ Immunol200818095771577718424693
   PubMed Web of Science ®Google Scholar
• O’GarraAVieiraPTH1 cells control themselves by producing interleukin-10Nat Rev Immunol20077642542817525751
   PubMed Web of Science ®Google Scholar
• MooreKWO’garraAMalefytRDWVieiraPMosmannTRInterleukin-10Annu Rev Immunol19931111651908386517
   PubMed Web of Science ®Google Scholar
• PradhanPQinHLeleuxJAThe effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphomaBiomaterials201435215491550424720881
   PubMed Web of Science ®Google Scholar
• LiuGNgHAkasakiYSmall interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 responseEur J Immunol20043461680168715162438
   PubMed Web of Science ®Google Scholar
• RoyASinghMSUpadhyayPBhaskarSCombined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approachMol Pharm2010751778178820822093
   PubMed Web of Science ®Google Scholar
• MaWChenMKaushalSPLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responsesInt J Nanomedicine201271475148722619507
   PubMed Web of Science ®Google Scholar
• SethAHeoMBLimYTPoly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapyBiomaterials201435277992800124954733
   PubMed Web of Science ®Google Scholar
• HeoMBLimYTProgrammed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cellsBiomaterials201435159060024125775
   PubMed Web of Science ®Google Scholar
• KimJHNohYWHeoMBChoMYLimYTMultifunctional hybrid nanoconjugates for efficient in vivo delivery of immunomodulating oligonucleotides and enhanced antitumor immunityAngew Chem Int Ed Engl201251389670967322915476
   PubMed Web of Science ®Google Scholar